nodes	percent_of_prediction	percent_of_DWPC	metapath
Niclosamide—STAT3—multiple sclerosis	0.843	1	CbGaD
Niclosamide—STAT3—brainstem—multiple sclerosis	0.00258	0.171	CbGeAlD
Niclosamide—STAT3—retina—multiple sclerosis	0.00248	0.165	CbGeAlD
Niclosamide—STAT3—medulla oblongata—multiple sclerosis	0.0018	0.119	CbGeAlD
Niclosamide—STAT3—midbrain—multiple sclerosis	0.00164	0.109	CbGeAlD
Niclosamide—STAT3—spinal cord—multiple sclerosis	0.0016	0.106	CbGeAlD
Niclosamide—STAT3—nervous system—multiple sclerosis	0.00135	0.0897	CbGeAlD
Niclosamide—STAT3—central nervous system—multiple sclerosis	0.0013	0.0863	CbGeAlD
Niclosamide—STAT3—cerebellum—multiple sclerosis	0.00127	0.0844	CbGeAlD
Niclosamide—STAT3—brain—multiple sclerosis	0.00103	0.0685	CbGeAlD
Niclosamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000242	0.0017	CbGpPWpGaD
Niclosamide—STAT3—Leptin signaling pathway—IL1B—multiple sclerosis	0.00024	0.00169	CbGpPWpGaD
Niclosamide—STAT3—IL2-mediated signaling events—MAPK1—multiple sclerosis	0.000238	0.00168	CbGpPWpGaD
Niclosamide—STAT3—FGF signaling pathway—MAPK1—multiple sclerosis	0.000238	0.00168	CbGpPWpGaD
Niclosamide—STAT3—IL-4 Signaling Pathway—MAPK1—multiple sclerosis	0.000238	0.00168	CbGpPWpGaD
Niclosamide—STAT3—CXCR4-mediated signaling events—CD4—multiple sclerosis	0.000238	0.00167	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—CD86—multiple sclerosis	0.000235	0.00165	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—CD86—multiple sclerosis	0.00023	0.00162	CbGpPWpGaD
Niclosamide—STAT3—TGF-beta Receptor Signaling—TNF—multiple sclerosis	0.000227	0.0016	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—CD28—multiple sclerosis	0.000224	0.00158	CbGpPWpGaD
Niclosamide—STAT3—Kit receptor signaling pathway—MAPK1—multiple sclerosis	0.000222	0.00156	CbGpPWpGaD
Niclosamide—STAT3—Notch Signaling Pathway—MYC—multiple sclerosis	0.000221	0.00155	CbGpPWpGaD
Niclosamide—STAT3—IL-6 signaling pathway—IL6—multiple sclerosis	0.00022	0.00154	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—IFNB1—multiple sclerosis	0.000217	0.00152	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-DPB1—multiple sclerosis	0.000217	0.00152	CbGpPWpGaD
Niclosamide—STAT3—Neurotrophic factor-mediated Trk receptor signaling—MAPK1—multiple sclerosis	0.000216	0.00152	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—TYK2—multiple sclerosis	0.000215	0.00151	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—SPP1—multiple sclerosis	0.00021	0.00147	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—CD86—multiple sclerosis	0.000208	0.00146	CbGpPWpGaD
Niclosamide—STAT3—TSH signaling pathway—MYC—multiple sclerosis	0.000207	0.00146	CbGpPWpGaD
Niclosamide—STAT3—CXCR4-mediated signaling events—MMP9—multiple sclerosis	0.000207	0.00146	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IFNB1—multiple sclerosis	0.000207	0.00145	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—CD80—multiple sclerosis	0.000206	0.00145	CbGpPWpGaD
Niclosamide—STAT3—Oncostatin M Signaling Pathway—MAPK1—multiple sclerosis	0.000205	0.00144	CbGpPWpGaD
Niclosamide—STAT3—Rac1/Pak1/p38/MMP-2 pathway—MYC—multiple sclerosis	0.000205	0.00144	CbGpPWpGaD
Niclosamide—STAT3—TSLP Signaling Pathway—IL6—multiple sclerosis	0.000205	0.00144	CbGpPWpGaD
Niclosamide—STAT3—IL6-mediated signaling events—IL6—multiple sclerosis	0.000205	0.00144	CbGpPWpGaD
Niclosamide—STAT3—AGE/RAGE pathway—MAPK1—multiple sclerosis	0.000203	0.00143	CbGpPWpGaD
Niclosamide—STAT3—TSH signaling pathway—MAPK1—multiple sclerosis	0.000203	0.00143	CbGpPWpGaD
Niclosamide—STAT3—Rac1/Pak1/p38/MMP-2 pathway—MAPK1—multiple sclerosis	0.0002	0.00141	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—CD80—multiple sclerosis	0.000185	0.0013	CbGpPWpGaD
Niclosamide—STAT3—Signaling events mediated by HDAC Class I—TNF—multiple sclerosis	0.000184	0.0013	CbGpPWpGaD
Niclosamide—STAT3—Leptin signaling pathway—MAPK1—multiple sclerosis	0.000183	0.00129	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—PRNP—multiple sclerosis	0.000183	0.00129	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—VCAM1—multiple sclerosis	0.000181	0.00127	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-DQA1—multiple sclerosis	0.000181	0.00127	CbGpPWpGaD
Niclosamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00018	0.00127	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—IL1B—multiple sclerosis	0.00018	0.00126	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—IL2—multiple sclerosis	0.000179	0.00126	CbGpPWpGaD
Niclosamide—STAT3—Immune System—P2RX7—multiple sclerosis	0.000176	0.00124	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—TYK2—multiple sclerosis	0.000174	0.00122	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—CD80—multiple sclerosis	0.000171	0.00121	CbGpPWpGaD
Niclosamide—STAT3—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—multiple sclerosis	0.000171	0.0012	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-DQB1—multiple sclerosis	0.000169	0.00119	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—CD80—multiple sclerosis	0.000168	0.00118	CbGpPWpGaD
Niclosamide—STAT3—MicroRNAs in cardiomyocyte hypertrophy—MAPK1—multiple sclerosis	0.000167	0.00118	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD226—multiple sclerosis	0.000164	0.00115	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000161	0.00113	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—CD86—multiple sclerosis	0.00016	0.00113	CbGpPWpGaD
Niclosamide—STAT3—MicroRNAs in cardiomyocyte hypertrophy—TNF—multiple sclerosis	0.000159	0.00112	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-DRB4—multiple sclerosis	0.000159	0.00112	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—TYK2—multiple sclerosis	0.000156	0.0011	CbGpPWpGaD
Niclosamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000154	0.00108	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-B—multiple sclerosis	0.000152	0.00107	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—CD80—multiple sclerosis	0.000152	0.00107	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000151	0.00106	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000151	0.00106	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CIITA—multiple sclerosis	0.00015	0.00105	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000148	0.00104	CbGpPWpGaD
Niclosamide—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000148	0.00104	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—TYK2—multiple sclerosis	0.000145	0.00102	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL2RA—multiple sclerosis	0.000142	0.001	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—PTPRC—multiple sclerosis	0.000142	0.001	CbGpPWpGaD
Niclosamide—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000142	0.001	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—TYK2—multiple sclerosis	0.000142	0.000996	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-A—multiple sclerosis	0.000141	0.00099	CbGpPWpGaD
Niclosamide—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.00014	0.000984	CbGpPWpGaD
Niclosamide—STAT3—Senescence-Associated Secretory Phenotype (SASP)—MAPK1—multiple sclerosis	0.00014	0.000984	CbGpPWpGaD
Niclosamide—STAT3—ErbB1 downstream signaling—MAPK1—multiple sclerosis	0.00014	0.000984	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL7—multiple sclerosis	0.000139	0.00098	CbGpPWpGaD
Niclosamide—STAT3—Immune System—C4A—multiple sclerosis	0.000139	0.00098	CbGpPWpGaD
Niclosamide—STAT3—Disease—GPC5—multiple sclerosis	0.000138	0.000973	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—MAPK1—multiple sclerosis	0.000137	0.000962	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—MMP9—multiple sclerosis	0.000137	0.000962	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PDCD1—multiple sclerosis	0.000134	0.00094	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—LINGO1—multiple sclerosis	0.000131	0.000925	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL7R—multiple sclerosis	0.000131	0.000922	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000129	0.000905	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000129	0.000905	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—HLA-DRB1—multiple sclerosis	0.000129	0.000904	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—TYK2—multiple sclerosis	0.000128	0.000902	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000127	0.000892	CbGpPWpGaD
Niclosamide—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000127	0.000892	CbGpPWpGaD
Niclosamide—STAT3—PDGFR-beta signaling pathway—MYC—multiple sclerosis	0.000124	0.000875	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—ICAM1—multiple sclerosis	0.000123	0.000868	CbGpPWpGaD
Niclosamide—STAT3—PDGFR-beta signaling pathway—MAPK1—multiple sclerosis	0.000122	0.000856	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CBLB—multiple sclerosis	0.00012	0.000846	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—TGFB1—multiple sclerosis	0.00012	0.000846	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—CD80—multiple sclerosis	0.000117	0.000822	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TAGAP—multiple sclerosis	0.000114	0.000802	CbGpPWpGaD
Niclosamide—Diflunisal—ALB—multiple sclerosis	0.000113	0.658	CrCbGaD
Niclosamide—STAT3—Adipogenesis—TNF—multiple sclerosis	0.000112	0.00079	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—MAPK1—multiple sclerosis	0.000111	0.000777	CbGpPWpGaD
Niclosamide—STAT3—BDNF signaling pathway—MAPK1—multiple sclerosis	0.000109	0.000764	CbGpPWpGaD
Niclosamide—STAT3—Senescence-Associated Secretory Phenotype (SASP)—IL6—multiple sclerosis	0.000108	0.000756	CbGpPWpGaD
Niclosamide—STAT3—Immune System—MX1—multiple sclerosis	0.000107	0.000751	CbGpPWpGaD
Niclosamide—STAT3—Signaling by Interleukins—IL6—multiple sclerosis	0.000105	0.000739	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-DRA—multiple sclerosis	0.000103	0.000727	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—TYK2—multiple sclerosis	0.0001	0.000705	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—S1PR1—multiple sclerosis	9.96e-05	0.000701	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—MAPK1—multiple sclerosis	9.94e-05	0.000699	CbGpPWpGaD
Niclosamide—STAT3—EGF/EGFR Signaling Pathway—MAPK1—multiple sclerosis	9.89e-05	0.000696	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—TYK2—multiple sclerosis	9.86e-05	0.000694	CbGpPWpGaD
Niclosamide—STAT3—Immune System—NOD1—multiple sclerosis	9.75e-05	0.000686	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—GPC5—multiple sclerosis	9.69e-05	0.000682	CbGpPWpGaD
Niclosamide—STAT3—Immune System—MALT1—multiple sclerosis	9.41e-05	0.000662	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IFNG—multiple sclerosis	9.39e-05	0.000661	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IRF5—multiple sclerosis	9.26e-05	0.000651	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—MAPK1—multiple sclerosis	9.21e-05	0.000648	CbGpPWpGaD
Niclosamide—STAT3—Adipogenesis—IL6—multiple sclerosis	9.06e-05	0.000637	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—MAPK1—multiple sclerosis	9.01e-05	0.000634	CbGpPWpGaD
Niclosamide—STAT3—Disease—RPL5—multiple sclerosis	9e-05	0.000633	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—MAPK1—multiple sclerosis	8.86e-05	0.000623	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IFIH1—multiple sclerosis	8.85e-05	0.000623	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IRF8—multiple sclerosis	8.85e-05	0.000623	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-G—multiple sclerosis	8.85e-05	0.000623	CbGpPWpGaD
Niclosamide—STAT3—Disease—SLC11A1—multiple sclerosis	8.62e-05	0.000606	CbGpPWpGaD
Niclosamide—STAT3—Signaling by SCF-KIT—IL6—multiple sclerosis	8.49e-05	0.000597	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—RGS1—multiple sclerosis	8.47e-05	0.000596	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL1B—multiple sclerosis	8.38e-05	0.000589	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL2—multiple sclerosis	8.35e-05	0.000587	CbGpPWpGaD
Niclosamide—STAT3—Immune System—TNFAIP3—multiple sclerosis	8.29e-05	0.000583	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—MAPK1—multiple sclerosis	8.16e-05	0.000574	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—GPR65—multiple sclerosis	8.03e-05	0.000565	CbGpPWpGaD
Niclosamide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.87e-05	0.000553	CbGpPWpGaD
Niclosamide—STAT3—Downstream signal transduction—IL6—multiple sclerosis	7.64e-05	0.000537	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD28—multiple sclerosis	7.46e-05	0.000524	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CXCL13—multiple sclerosis	7.35e-05	0.000517	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCR1—multiple sclerosis	7.35e-05	0.000517	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CCR2—multiple sclerosis	7.32e-05	0.000515	CbGpPWpGaD
Niclosamide—STAT3—Immune System—PTPRC—multiple sclerosis	7.32e-05	0.000515	CbGpPWpGaD
Niclosamide—STAT3—Signaling by FGFR in disease—IL6—multiple sclerosis	7.08e-05	0.000498	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-DPB1—multiple sclerosis	7.08e-05	0.000498	CbGpPWpGaD
Niclosamide—STAT3—Signaling by PDGF—IL6—multiple sclerosis	6.92e-05	0.000487	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	6.92e-05	0.000486	CbGpPWpGaD
Niclosamide—STAT3—Disease—CD28—multiple sclerosis	6.88e-05	0.000484	CbGpPWpGaD
Niclosamide—STAT3—Immune System—ITGA4—multiple sclerosis	6.81e-05	0.000479	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD40—multiple sclerosis	6.81e-05	0.000479	CbGpPWpGaD
Niclosamide—STAT3—Cellular Senescence—IL6—multiple sclerosis	6.8e-05	0.000479	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IFNB1—multiple sclerosis	6.76e-05	0.000475	CbGpPWpGaD
Niclosamide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.72e-05	0.000473	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CTLA4—multiple sclerosis	6.71e-05	0.000472	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—MAPK1—multiple sclerosis	6.69e-05	0.000471	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—MAPK1—multiple sclerosis	6.38e-05	0.000449	CbGpPWpGaD
Niclosamide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.38e-05	0.000448	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—TYK2—multiple sclerosis	6.37e-05	0.000448	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—MAPK1—multiple sclerosis	6.28e-05	0.000441	CbGpPWpGaD
Niclosamide—STAT3—NGF signalling via TRKA from the plasma membrane—IL6—multiple sclerosis	6.27e-05	0.000441	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	6.17e-05	0.000434	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	6.15e-05	0.000432	CbGpPWpGaD
Niclosamide—STAT3—Immune System—VCAM1—multiple sclerosis	5.92e-05	0.000416	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-DQA1—multiple sclerosis	5.91e-05	0.000415	CbGpPWpGaD
Niclosamide—Clonazepam—ALB—multiple sclerosis	5.89e-05	0.342	CrCbGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.78e-05	0.000407	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.78e-05	0.000407	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-DQB1—multiple sclerosis	5.52e-05	0.000388	CbGpPWpGaD
Niclosamide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.45e-05	0.000383	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD86—multiple sclerosis	5.32e-05	0.000374	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCL3—multiple sclerosis	5.23e-05	0.000368	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD40LG—multiple sclerosis	5.22e-05	0.000367	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD8A—multiple sclerosis	5.16e-05	0.000363	CbGpPWpGaD
Niclosamide—STAT3—Cellular responses to stress—IL6—multiple sclerosis	5.14e-05	0.000362	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PTGER4—multiple sclerosis	5.04e-05	0.000354	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MMP9—multiple sclerosis	5.02e-05	0.000353	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-B—multiple sclerosis	4.96e-05	0.000349	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—PGR—multiple sclerosis	4.96e-05	0.000349	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.94e-05	0.000347	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.94e-05	0.000347	CbGpPWpGaD
Niclosamide—STAT3—Disease—CD86—multiple sclerosis	4.91e-05	0.000345	CbGpPWpGaD
Niclosamide—STAT3—Cytokine Signaling in Immune system—IL6—multiple sclerosis	4.91e-05	0.000345	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CXCR3—multiple sclerosis	4.87e-05	0.000342	CbGpPWpGaD
Niclosamide—STAT3—Signaling by NGF—IL6—multiple sclerosis	4.82e-05	0.000339	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CD28—multiple sclerosis	4.82e-05	0.000339	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.81e-05	0.000338	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	4.79e-05	0.000337	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCR2—multiple sclerosis	4.73e-05	0.000333	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.7e-05	0.000331	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL2RA—multiple sclerosis	4.65e-05	0.000327	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-A—multiple sclerosis	4.6e-05	0.000323	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.48e-05	0.000315	CbGpPWpGaD
Niclosamide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.48e-05	0.000315	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CNR1—multiple sclerosis	4.37e-05	0.000307	CbGpPWpGaD
Niclosamide—STAT3—Disease—CCR5—multiple sclerosis	4.36e-05	0.000306	CbGpPWpGaD
Niclosamide—STAT3—Disease—HLA-A—multiple sclerosis	4.24e-05	0.000299	CbGpPWpGaD
Niclosamide—STAT3—Immune System—TLR4—multiple sclerosis	4.2e-05	0.000296	CbGpPWpGaD
Niclosamide—STAT3—Immune System—HLA-DRB1—multiple sclerosis	4.2e-05	0.000295	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—TGFB1—multiple sclerosis	4.13e-05	0.000291	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—MAPK1—multiple sclerosis	4.05e-05	0.000285	CbGpPWpGaD
Niclosamide—STAT3—Immune System—ICAM1—multiple sclerosis	4.03e-05	0.000284	CbGpPWpGaD
Niclosamide—STAT3—Disease—APOE—multiple sclerosis	3.96e-05	0.000279	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CXCL10—multiple sclerosis	3.93e-05	0.000277	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD80—multiple sclerosis	3.88e-05	0.000273	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—TNF—multiple sclerosis	3.86e-05	0.000271	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—SRM—multiple sclerosis	3.65e-05	0.000257	CbGpPWpGaD
Niclosamide—STAT3—Disease—CD80—multiple sclerosis	3.58e-05	0.000252	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CD86—multiple sclerosis	3.44e-05	0.000242	CbGpPWpGaD
Niclosamide—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.39e-05	0.000238	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCL5—multiple sclerosis	3.39e-05	0.000238	CbGpPWpGaD
Niclosamide—STAT3—Immune System—TYK2—multiple sclerosis	3.28e-05	0.00023	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—SPP1—multiple sclerosis	3.14e-05	0.000221	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—SRM—multiple sclerosis	3.12e-05	0.00022	CbGpPWpGaD
Niclosamide—STAT3—Developmental Biology—IL6—multiple sclerosis	3.11e-05	0.000219	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IFNG—multiple sclerosis	3.07e-05	0.000216	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCR5—multiple sclerosis	3.05e-05	0.000215	CbGpPWpGaD
Niclosamide—STAT3—Disease—TYK2—multiple sclerosis	3.02e-05	0.000213	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL2RA—multiple sclerosis	3.01e-05	0.000211	CbGpPWpGaD
Niclosamide—STAT3—Immune System—CD4—multiple sclerosis	2.96e-05	0.000208	CbGpPWpGaD
Niclosamide—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.89e-05	0.000204	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—APOE—multiple sclerosis	2.77e-05	0.000195	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL1B—multiple sclerosis	2.74e-05	0.000192	CbGpPWpGaD
Niclosamide—STAT3—Disease—CD4—multiple sclerosis	2.74e-05	0.000192	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL2—multiple sclerosis	2.73e-05	0.000192	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.57e-05	0.000181	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.57e-05	0.000181	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.52e-05	0.000177	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CD80—multiple sclerosis	2.51e-05	0.000176	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—POMC—multiple sclerosis	2.38e-05	0.000168	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.36e-05	0.000166	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—CCL2—multiple sclerosis	2.33e-05	0.000164	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.2e-05	0.000155	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.2e-05	0.000155	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.15e-05	0.000151	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TYK2—multiple sclerosis	2.12e-05	0.000149	CbGpPWpGaD
Niclosamide—STAT3—Immune System—MAPK1—multiple sclerosis	2.09e-05	0.000147	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—GPC5—multiple sclerosis	2.01e-05	0.000142	CbGpPWpGaD
Niclosamide—STAT3—Disease—MYC—multiple sclerosis	1.97e-05	0.000138	CbGpPWpGaD
Niclosamide—STAT3—Disease—TGFB1—multiple sclerosis	1.96e-05	0.000138	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.95e-05	0.000137	CbGpPWpGaD
Niclosamide—STAT3—Disease—MAPK1—multiple sclerosis	1.93e-05	0.000135	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL2—multiple sclerosis	1.76e-05	0.000124	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MMP9—multiple sclerosis	1.67e-05	0.000117	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.67e-05	0.000117	CbGpPWpGaD
Niclosamide—STAT3—Immune System—IL6—multiple sclerosis	1.6e-05	0.000113	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.51e-05	0.000106	CbGpPWpGaD
Niclosamide—STAT3—Disease—IL6—multiple sclerosis	1.48e-05	0.000104	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MYC—multiple sclerosis	1.38e-05	9.69e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—TGFB1—multiple sclerosis	1.37e-05	9.67e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—MAPK1—multiple sclerosis	1.35e-05	9.48e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.3e-05	9.15e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.29e-05	9.1e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.19e-05	8.34e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.12e-05	7.88e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.11e-05	7.82e-05	CbGpPWpGaD
Niclosamide—STAT3—Signaling Pathways—IL6—multiple sclerosis	1.04e-05	7.29e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.01e-05	7.13e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—BCHE—multiple sclerosis	9.58e-06	6.74e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—APOE—multiple sclerosis	6.74e-06	4.74e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—POMC—multiple sclerosis	5.79e-06	4.07e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—APOE—multiple sclerosis	5.76e-06	4.05e-05	CbGpPWpGaD
Niclosamide—CYP2C9—Metabolism—ALB—multiple sclerosis	5.28e-06	3.71e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—POMC—multiple sclerosis	4.95e-06	3.48e-05	CbGpPWpGaD
Niclosamide—CYP1A2—Metabolism—ALB—multiple sclerosis	4.51e-06	3.17e-05	CbGpPWpGaD
